News about "to develop large-scale manufacturing process for v"

To develop large-scale manufacturing process for viral vector-based vaccines, IDT Biologika, Exothera collaborates

To develop large-scale manufacturing process for viral vector-based vaccines, IDT Biologika, Exothera collaborates

The feasibility study is focussing on Modified Vaccinia Ankara (MVA) virus as a first example for IDT's broad range of vector technologies

To Develop Large-scale Manufacturing Process For V | 02/03/2022 | By Darshana 505


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members